MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Very few people are aware of MASLD and its health implications, including those living with it - Madona Azar
HWN Suggests
Millions in west do not know they have aggressive fatty liver disease, study says
More than 15 million people in the US, UK, Germany and France do not know they have the most aggressive form of fatty liver disease, according to research. Metabolic dysfunction-associated steatotic liver disease (MASLD) – the formal name for non-alcoholic fatty liver disease – occurs in people who drink no or minimal amounts of alcohol whose liver contains more than 5% fat. About two-thirds of patients with type 2 diabetes are thought to have the condition, which is also associated with obesity, heart and circulatory disease. Approximately 5% of adults globally have the most aggressive form of MASLD. Metabolic dysfunction-associated steatohepatitis (MASH) causes fibrosis (scarring) and can…
Featured
This Disease Can Damage the Liver for Years Without Being Detected
Four in 10 people are thought to have a potentially serious liver condition known as MASLD. Reversing it is possible if you catch it early. “It’s largely asymptomatic, until it’s not,” said Dr. Meena B. Bansal, chief of the division of liver diseases at the Icahn School of Medicine at Mount Sinai in New York. “And usually when it’s symptomatic it’s quite advanced.”
Articles of Interest
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
Diagnosing and managing metabolic dysfunction-associated steatotic liver disease (MASLD) remains a major challenge in primary care due to lack of agreement on diagnostic tools, difficulty in identifying symptoms and determining their cause, absence of approved pharmacological treatments, and limited awareness of the disease. However, prompt diagnosis and management are critical to preventing MASLD from progressing to more severe forms of liver disease.
Diabetes and obesity can damage the liver to the point of failure – but few people know their risk of developing liver disease
MASLD is a complex disorder with both environmental and genetic contributions. In its early stages, liver cells accumulate fat in a process called steatosis. Major sources of this fat include adipose tissue as well as fatty acids the liver makes in response to insulin resistance and excess caloric intake. This fat accumulation can enlarge the liver and interfere with its normal functioning.
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), poses a significant global health challenge due to its increasing prevalence and strong association with cardiovascular disease (CVD).
New Year, New Name: NAFLD becomes MASLD
We now know that NAFLD/MASLD can co-exist with other types of liver disease, including alcoholic liver disease, and many concerns have been raised over the last few decades that “[NAFLD] trivialized the disease and ... would sometimes make patients feel bad to hear ‘fatty’ or a tie to alcohol.” There was also hope that this new label would spur needed research into a condition with limited treatment options that is rapidly increasing in prevalence across the developed world.
Renamed, common liver diseases might get fairer shake at treatment, researchers hope
Renamed, common liver diseases might get fairer shake at treatment, researchers hop. A group of over 200 physicians, public health experts, industry representatives, regulatory officials, and patient advocates made the call in a supermajority vote: Non-alcoholic fatty liver disease, or NAFLD, would be renamed metabolic dysfunction-associated steatotic liver disease. MASLD for short (pronounced MAA-zuld).
The Facts About Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
MASLD (metabolic dysfunction-associated steatotiic liver disease) is the buildup of extra fat in liver cells that is not caused by alcohol. It is normal for the liver to contain some fat; however, if more than five to ten percent of the liver’s weight is fat, it is considered to be steatosis (fatty liver). MASLD tends to develop in people who are overweight or obese, or have type 2 diabetes, high cholesterol or high triglycerides. Rapid weight loss and poor eating habits also may lead to MASLD. Some people, however, develop MASLD even if they don’t have any known risk factors.
To Fight Fatty Liver, Avoid Sugary Foods and Drinks
Children with fatty liver disease sharply reduced the amount of fat and inflammation in their livers by cutting soft drinks, fruit juices and foods with added sugars.
30% of Americans Have This Obesity-Related Disease
Nonalcoholic fatty liver disease, or NAFLD, is an umbrella term for several stages of disease. Most people with NAFLD have what’s known as simple fatty liver, which means that more than 5% of the liver is made up of fat cells. (Fat in the liver can also be a product of heavy alcohol use, which is known as alcoholic fatty liver disease.)
Can You Reverse Fatty Liver?
The short answer is yes. Nonalcoholic fatty liver disease, which affects about one in five adults in the United States, is tightly linked to the obesity epidemic. There are no drugs to treat the disease, so most clinicians recommend that patients focus on lifestyle changes that produce weight loss, like diet and exercise, to improve their prognoses. Unchecked, fatty liver disease can lead to liver failure.
Diagnosing Fatty Liver
Right now the gold standard of diagnosis is liver biopsy. This involves inserting a long needle into the abdomen to remove a small sample of liver tissue, which can then be examined to determine whether the cells are burdened with fat or inflammation. Because the procedure is invasive and can be painful, doctors usually reserve liver biopsies for cases where they strongly suspect fatty liver or the more advanced form of the disease,
Does My Liver Look Fat in This?
“Non-alcoholic fatty liver disease is currently the most common liver disease in most of the Western world, affecting 30 percent of adults and 10 percent of children — and this number is growing,” warns Tamar Taddei, M.D., associate professor of medicine, section of digestive diseases at the Yale School of Medicine and a member of the American Liver Foundation’s medical advisory committee.
Experts warn of fatty liver disease 'epidemic' in young people
Study finds substantial numbers of young people at risk of liver cancer, diabetes and heart attacks.
Experts warn of fatty liver disease 'epidemic' in young people
Study finds substantial numbers of young people at risk of liver cancer, diabetes and heart attacks.
Fatty Liver
Unchecked, the disease can lead to liver transplant and possible fatality. The good news is that in the vast majority of cases, fatty liver can be managed, or even reversed, through a few simple action steps.
Fatty Liver Disease: More Prevalent in Children
The disease's prevalence is alarming doctors who worry about its progression to nonalcoholic steatohepatitis, or NASH, when the fatty liver becomes inflamed and cells are damaged. That leads to the end stage of cirrhosis, when the liver forms scar tissue and ultimately stops working.
Fatty liver disease: What it is and what to do about it
There are lots of medical terms related to fatty liver disease, and it can get confusing. The main medical umbrella term NAFLD refers to a fatty liver that is not related to alcohol use. NAFLD is further divided into two groups: Non-alcoholic fatty liver (NAFL), otherwise known as simple fatty liver, or Non-alcoholic steatohepatitis (NASH)
Fatty Liver Is More Dangerous Than You Might Realize. Here’s How to Heal It
What’s so bad about having a fatty liver? Well, among its numerous repercussions include inflammation, which triggers insulin resistance and pre-diabetes, meaning your body deposits fat in your liver and organs including your belly (called visceral fat).
Is Fatty Liver Disease the New Diabetes?
Horton says those who are prediabetic or are overweight or obese should especially take notice of this study, given that fatty liver disease is so closely associated with the two.
MASLD, NAFLD and fatty liver disease
MASLD, NAFLD and fatty liver disease are different names for the same condition. You can read more about the different names and what they mean below. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a long-lasting liver condition caused by having too much fat in the liver. It is closely linked with being overweight as well as conditions such as type 2 diabetes and heart and circulatory disease. Metabolic dysfunction-associated steatohepatitis (MASH, previously called NASH) is a more serious stage of MASLD. In a small number of people it can lead to liver cancer or liver failure.
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
MASH is usually first suspected in a person who is found to have elevations in liver tests that are included in routine blood test panels, such as alanine aminotransferase (ALT) or aspartate aminotransferase (AST). When further evaluation shows no apparent reason for liver disease (such as medications, viral hepatitis, or excessive use of alcohol) and when x rays or imaging studies of the liver show fat, MASH is suspected. The only means of proving a diagnosis of MASH and separating it from simple fatty liver is a liver biopsy.
Renamed, common liver diseases might get fairer shake at treatment, researchers hope
A group of over 200 physicians, public health experts, industry representatives, regulatory officials, and patient advocates made the call in a supermajority vote: Non-alcoholic fatty liver disease, or NAFLD, would be renamed metabolic dysfunction-associated steatotic liver disease. MASLD for short (pronounced MAA-zuld).
Surprising Fatty Liver Results Could Put Madrigal in Big Pharma’s Sights
With solid data, the market will now get to test out whether there really is a big market for fatty liver disease. Of course, the best way to tackle fatty liver disease, just like other illnesses generally caused by obesity, will always be to make lifestyle adjustments such as cutting down on unhealthy foods. But with obesity sadly unlikely to go away anytime soon, treating its effects on the liver will continue to be important. Now there may finally be a treatment on the way, and big pharma isn’t likely to want to miss out on that.
The Effects of Physical Exercise on Fatty Liver Disease
The increasing prevalence of obesity has made nonalcoholic fatty liver disease (NAFLD) the most common chronic liver disease. As a consequence, NAFLD and especially its inflammatory form nonalcoholic steatohepatitis (NASH) are the fastest increasing etiology of end-stage liver disease and hepatocellular carcinoma.
The Invention of an Illness
Fatty liver disease has gone from unknown to pandemic, but does it mean anything?
Threat Grows From Liver Illness Tied to Obesity
Despite major gains in fighting hepatitis C and other chronic liver conditions, public health officials are now faced with a growing epidemic of liver disease that is tightly linked to the obesity crisis.
To Fight Fatty Liver, Avoid Sugary Foods and Drinks
Children with fatty liver disease sharply reduced the amount of fat and inflammation in their livers by cutting soft drinks, fruit juices and foods with added sugars.
Treatment for obesity and fatty liver disease may be in reach
Researchers have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.
Uncovering the genetic causes of fatty liver disease — a growing health concern
Non-alcoholic fatty liver disease is a disease that affects, on average, one in four adults and nearly one in 10 children worldwide. The disease progresses from reversible to irreversible stages. The first stage is defined by the presence of steatosis (excessive accumulation of lipids in the liver to at least five per cent of the total liver mass). The next stage, which is also reversible, is characterized by inflammation of the liver cells (called hepatocytes). This inflammation may be accompanied by scar tissue (called fibrosis).
What's the Big Deal About a Fatty Liver?
For those patients who have been diagnosed with non-alcoholic fatty liver disease, it is the leading cause of chronic liver disease in the United States and other Western countries.
Why fatty liver disease is on the rise
Fatty liver disease was once seen mostly in heavy drinkers. Now, at least a third of adults in Canada have it—and it’s hard to diagnose
Why You Might Get Liver Disease Even If You’re Not Much of a Drinker
Experts consider this the next epidemic.
Resources
30% of Americans Have This Obesity-Related Disease
About 30% to 40% of American adults have a condition that has no visible signs and rarely causes symptoms, but can raise the risk of heart disease, diabetes, cirrhosis and liver cancer. It’s called nonalcoholic fatty liver disease—and as American waistlines continue to expand, the prevalence of this dangerous condition is growing as well.
7 Facts About Fatty Liver Disease, MASLD, and MASH
MASLD and MASH are diseases caused by the buildup of liver fat. Unlike some other liver diseases, MASLD and MASH are not caused by alcohol. Recently, health experts agreed to rename nonalcoholic fatty liver disease (NAFLD) to MASLD. Nonalcoholic steatohepatitis (NASH) is now known as MASH. You may see NAFLD and NASH still used elsewhere.
Fatty Liver Alliance
Advancing awareness and advocacy for MASLD and MASH...
Fatty Liver Diary
Everything about fatty liver, from somebody who managed to reverse NAFLD
